The Board has remanded several issues related to the effective dates and service connection for AML, including a motion to revise the November 2005 rating decision on CUE grounds. The propriety of the January 2022 rating decision regarding the effective date for accrued benefits purposes is also under review.
The deciding factor: The Board found procedural errors in the handling of the severance and reduction in evaluation process, necessitating further action by the RO to ensure proper notice procedures are followed.
- Claimed conditions
- Acute Myelogenous Leukemia (AML)
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 13, 2024
- Citation
- A24074251
Veterans Law Judge
Decisions by this judge: 882 · Granted: 22% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24074251.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board has determined that the Veteran's cause of death, Acute Myelogenous Leukemia (AML), is related to his in-service exposure to herbicide agents. After considering all evidence and resolving all reasonable doubt in favor of the claimant, service connection for AML due to herbicide exposure is granted.
- Partly granted
The Board denied service connection for various conditions and granted an initial 20 percent rating for right lower extremity deep vein thrombosis, while remanding several other issues.
- Remanded (sent back)
The Board has denied a compensable evaluation for AML with allogenic SCT from August 1, 2018. The appeal is remanded for further consideration of service connection claims related to hiatal hernia, dysphagia (difficulty swallowing), and an acquired mental disorder.
- Granted
The Veteran's service connection claim for Acute Myelogenous Leukemia (AML) is granted due to his in-service exposure to herbicide agents, specifically Agent Orange.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.